期刊文献+

浅析参苓白术散治疗腹泻型肠易激综合征临床机理 被引量:2

A brief analysis of the clinical mechanism of Shenling Baizhu San in the treatment of diarrheal irritable bowel syndrome
在线阅读 下载PDF
导出
摘要 肠易激综合征(Irritable bowel syndrome,IBS)是一种胃肠道功能紊乱性疾病,临床以腹泻型(IBS-D)最为常见,参苓白术散治疗IBS-D取得了较好的临床效果,但现在参苓白术散治疗IBS-D作用机制探讨较少,笔者从胃肠动力学、内脏高敏、肠黏膜屏障、肠道微环境等方面探讨参苓白术散对IBS-D治疗价值,以期更好的应用于临床。 Irritable bowel syndrome(IBS)is a gastrointestinal dysfunction disorder.The most common clinical type is diarrhea(IBS-D).It has better clinical effects,but now the mechanism of Shenling Baizhu Powder for treating IBS-D is less discussed.Now the author briefly discusses Shenling Baizhu Powder from gastrointestinal dynamics,visceral hypersensitivity,intestinal mucosal barrier,intestinal microenvir.
作者 许月月 陈敏 谢欣 果姗姗 彭昌蓝 XU Yue-yue;CHEN Min;XIE Xin;GUO Shan-shan;PENG Chang-lan(Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
出处 《内蒙古中医药》 2022年第4期59-60,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81774321) 国家重点研发计划(2019YFC1709004)。
关键词 腹泻型肠易激综合征 参苓白术散 综述 Diarrhea-type irritable bowel syndrome Shenling Baizhu San Review
作者简介 第一作者:许月月(1995-),女,汉族,四川资阳人,在读硕士,从事中医药防治肛肠疾病的临床研究;共同第一作者/通讯作者:陈敏(1982-),女,汉族,四川成都人,博士,副主任医师,硕士研究生导师,从事中医药防治肛肠疾病的临床与实验研究。
  • 相关文献

参考文献3

二级参考文献36

  • 1Philip Hilgard,Alisan Kahraman,Nils Lehmann,Cornelia Seltmann,Susanne Beckebaum,R Stefan Ross,Hideo A Baba,Massimo Malago,Christoph E Broelsch,Guido Gerken.Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:Effects on virus replication and recurrent hepatitis[J].World Journal of Gastroenterology,2006,12(5):697-702. 被引量:236
  • 2郝延军,桑育黎,李宝林,贾天柱.苍术酮的常温稳定性研究[J].中成药,2007,29(6):895-896. 被引量:39
  • 3Makker J, Chilimuri S, Bella J N. Genetic epidemiology of irrita- ble bowel syndrome [ J ]. World J Gastroenterol, 2015,21 (40) : 11353.
  • 4Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome[ J]. Clin Epidemiol, 2014,6:71.
  • 5Lovell R M, Ford A C. Global prevalence of and risk factors for irritable bowel syndrome: a Meta-analysis[ J ]. Clin Gastroenterol Hepatol, 2012,10(7) :712.
  • 6张吉,王春林.推拿治疗肠易激综合征的研究进展[C].昆明:首届兰茂中医药发展学术论坛暨云南省中医药界2014学术年会,2014.
  • 7yon Elm E, Altman D G, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies [ J ]. J Clin Epidemiol, 2008,61 (4) :344.
  • 8Chang L, Toner B B, Fukudo S, et al. Gender, age, soeiety, culture, and the patient's perspective in the functional gastrointes- tinal disorders [ J ]. Gastroenterology, 2006,130 ( 5 ) : 1435.
  • 9Vandvik P O, Lydersen S, Farup P G. Prealenee, eomorbidityand impact of irritable bowel syndrome in Norway [ J ]. Scand J Gastroenterol, 2006,41 (6) :650.
  • 10Talley N J, Zinsmeister A R, Melton L J. Irritable bowel syn- drome in a community: symptom subgroups, risk factors, and health care utilization[J]. Am J Epidemiol, 1995,142( 1 ) :76.

共引文献63

同被引文献49

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部